Heart failure & cardiomyopathies

Left ventricular remodeling in end-stage liver disease and post-transplant mortality assessed using end-diastolic pressure-volume relation analysis: Observational retrospective study

Am Heart JPublished Retrospective cohort study

Authors' conclusion

As ESLD advances, diastolic ventricular properties are characterized by increased EDVI20 and β on rightward-shifted EDPVR, indicating larger capacitance and higher stiffness. However, leftward-shifted EDPVR with left ventricle remodeling failure is associated with poor post-LT survival.

Study context

Population
Patients undergoing liver transplantation for end-stage liver disease; End-diastolic pressure-volume relationship (EDPVR) estimated from preoperative echocardiography1,090 with β > 6.16
Participants
3,211 patients
Exposure
Leftward-shifted and intermediate EDPVR vs rightward-shifted EDPVR
Outcome
Cumulative all-cause mortality after liver transplantation
Follow-up
11 years
Methodological detailsobservational
  • Observational

Main finding

As reported in the abstract

All-cause mortality after liver transplantation (LT) (patients with β > 6.16)

Leftward-shifted

73.7%

Survival

Rightward-shifted

82.9%

Survival

Adjusted Cox model
Each group vs rightward-shiftedHazard ratio (95% CI)
Leftward-shifted
1.93(1.27–2.92)
Intermediate
1.55(1.12–2.26)

Observational data: associations, not effects.

Further findings

EDPVR variables by liver disease severity (MELD score)

EDVI20 and β gradually increased as MELD score increased (larger capacitance, higher diastolic stiffness)

Variables associated with leftward-shifted EDPVR (SHAP model)

DM, female sex, old age and hypertension

Original publication

Left ventricular remodeling in end-stage liver disease and post-transplant mortality assessed using end-diastolic pressure-volume relation analysis: Observational retrospective study. Am Heart J. Published 11 April 2023. doi:10.1016/j.ahj.2023.04.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.